Search

Your search keyword '"Tumors -- Drug therapy -- Genetic aspects"' showing total 1 results
Start Over Descriptor "Tumors -- Drug therapy -- Genetic aspects" Publisher athena information solutions pvt. ltd.
1 results on '"Tumors -- Drug therapy -- Genetic aspects"'

1. Senhwa Biosciences seeks US FDA and Health Canada approvals for CX-5461 to treat solid tumors with BRCA2 or PALB2 mutations

Subjects
United States. Food and Drug Administration, Cancer treatment, Talazoparib, Cancer research -- Genetic aspects, Tumors -- Drug therapy -- Genetic aspects, Drug approval, Pharmaceuticals and cosmetics industries
Abstract

Senhwa Biosciences Inc, a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announced that it has submitted multiple Investigational New Drug (IND) [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results